Core Insights - Adia Nutrition Inc. has opened its first licensed clinic, Adia Med of San Antonio, under a strategic license agreement, led by Dr. Michele DeLeon [1][2] - The clinic aims to expand access to innovative regenerative therapies in the U.S. and will offer FDA-registered products, including AdiaVita and AdiaLink [1][2] - A clinical study focusing on regenerative therapies for autism will be conducted in collaboration with Adia Med of Winter Park, highlighting the company's commitment to transformative healthcare solutions [2] Company Overview - Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) focused on revolutionizing healthcare and supplementation through two main divisions: a supplement division and a medical division specializing in stem cell therapies [3] - The medical division emphasizes treatments involving Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) [3] - The company is dedicated to empowering individuals by addressing nutritional needs and providing groundbreaking medical treatments [3]